Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CTLA4 antibody

This Mouse Monoclonal antibody specifically detects CTLA4 in IF and BR. It exhibits reactivity toward Mouse.
Catalog No. ABIN7072468
$624.00
Plus shipping costs $50.00
200 μg
Shipping to: United States
Delivery in 7 to 13 Business Days

Quick Overview for Recombinant CTLA4 antibody (ABIN7072468)

Target

See all CTLA4 Antibodies
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Antibody Type

Recombinant Antibody

Reactivity

  • 172
  • 104
  • 51
  • 14
  • 10
Mouse

Host

  • 94
  • 93
  • 22
  • 19
  • 7
  • 2
  • 1
  • 1
  • 1
Mouse

Clonality

  • 168
  • 68
  • 3
Monoclonal

Conjugate

  • 114
  • 20
  • 19
  • 18
  • 13
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CTLA4 antibody is un-conjugated

Application

  • 94
  • 82
  • 66
  • 41
  • 29
  • 29
  • 26
  • 13
  • 10
  • 7
  • 7
  • 5
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
Immunofluorescence (IF), Blocking Reagent (BR)

Clone

9D9
  • Purpose

    Anti-CTLA-4 [9D9], Mouse IgG2b, kappa

    Specificity

    The antibody is specific for CTLA-4.

    Characteristics

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2b

    Purification

    Protein A affinity purified

    Immunogen

    The antibody was raised against CTLA-4.

    Isotype

    IgG2b kappa
  • Application Notes

    The antibody has been used to block CTLA-4 and has been shown to enhance T-cell immunity against tumours (Quezada et al, 2006). 9D9 also has an anti-B16/BL6 melanoma effect in non-irradiated tumour-bearing recipients when given as combinatorial therapy with Gvax (Peggs et al, 2009). Selby et al. (PMID: 24777248) show how conversion of the original mouse IgG2b to a mouse IgG2a greatly increases anti-tumor activity of the 9D9 antibody in both MC38 (C57BL/6 mice) and CT26 (BALB/c mice) models. This mechanism both involves blockade of CTLA4 as well as depletion of tumor-infiltrating regulatory T-cells. Fc Silent antibodies were shown to have reduced anti-tumor activity as they did not deplete tumor infiltrating regulatory T-cells, however they lead to expansion of peripheral Tregs.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Alternative Name

    CTLA-4

    Background

    CD152, CTLA4, Cytotoxic T-Lymphocyte Associated Protein 4, Insulin-Dependent Diabetes Mellitus 12, Celiac Disease 3, Ligand And Transmembrane Spliced Cytotoxic T Lymphocyte Associated Antigen 4, Cytotoxic T Lymphocyte Associated Antigen 4 Short Spliced Fo

    UniProt

    P09793

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!